Cite

    Nelly Amara et al.. “Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.” Europace, vol. 20, no. 1, 2018, pp. 65–72. http://access.bl.uk/ark:/81055/vdc_100095511528.0x000027